Introduction: examination of clinical and preclinical pharmacologic data relating to abuse liability of l-deprenyl (selegiline).
Goldberg
S R
SR
Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD 21224.
Yasar
S
S
Bergman
J
J
Youdim
M B
MB
D000818:Animals; D006801:Humans; D012642:Selegiline / Q000009:adverse effects* / Q000633:toxicity; D019966:Substance-Related Disorders / Q000209:etiology*
D012642:Selegiline